Nevirapine
NDC 65162-209, Nevirapine, tablet, from Amneal Pharmaceuticals LLC.
- Product NDC
- 65162-209
- Status
- Listed
- Labeler
- Amneal Pharmaceuticals LLC
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA078195
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/65162-209 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- NEVIRAPINE200 mg/1
Pharmacologic classes
Cytochrome P450 2B6 Inducers [MoA]; Cytochrome P450 3A Inducers [MoA]; Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Non-Nucleoside Analog [EXT]; Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 65162-209-06 | 65162020906 | 60 TABLET in 1 BOTTLE (65162-209-06) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/4f065674-4719-4c79-ba0d-549040d77f17
Use it
Look up 65162-209 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/65162-209 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 65162-209. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.